Abstract:Objective To investigate the expressions and clinical significance of vascular endothelial growth fac -tor (VEGF) and inhibitor of apoptosis protein Survivin in lung adenocarcinoma.Methods The tumor tissue and para－carcinoma tissue samples from 75 cases of lung adenocarcinoma were collected from our hospital.Immunohistochemical SP method was applied to assess VEGF and Survivin expression.The follow－up of 3－5 years was obtained.The correlation of the expressions of VEGF and Survivin with the clinical characteristics and the prognosis of patients with lung adenocarci -noma were analyzed.Results The high expression rate of VEGF in lung adenocarcinoma tissues was significantly higher than that in para－carcinoma tissues (80.00%vs.14.76%, P＝0.000).The 5－year survival rate of the lung adeno-carcinoma patients with low expression of VEGF was significantly higher than that of the patients with high expression of VEGF (P＝0.029).The high expression rate of Survivin in lung adenocarcinoma tissues was significantly higher than that in para－carcinoma tissues (73.33%vs.1.33%, P＝0.000).The 5－year survival rate of the lung adenocarcinoma pa-tients with low expression of Survivin was significantly higher than that of the patients with high expression of Survivin (P＝0.032).The 5－year survival rate of the lung adenocarcinoma patients with high expression of VEGF and Survivin was significantly lower than those with low expression (P＝0.033); and the 5－year survival rate of the lung adenocarci-noma patients with high expression of VEGF or Survivin was significantly lower than those with low expression ( P＝0.031).The high expression of VEGF and Survivin in the lung adenocarcinoma tissues were positively correlated (r＝0.667, P＝0.000).Univariate analysis showed that VEGF , Survivin, tumor size, lymph node metastasis and clinical stage were the risk factors of poor prognosis of lung adenocarcinoma.Multivariate analysis showed that VEGF expression and clinical stage were independent risk factors for predicting lung cancer death .Conclusion The high expression of VEGF and Survivin in lung adenocarcinoma is positively correlated and is significant predictor of poor prognosis .

SOX5 Induces Lung Adenocarcinoma Angiogenesis by Inducing the Expression of VEGF Through STAT3 Signaling

SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

Identification of ATAD3A As a Key Regulator in Non-Small Cell Lung Cancer by Promoting STAT3-induced Cell Proliferation and Tumor Angiogenesis

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

Overexpression of Wnt5a Promotes Angiogenesis in NSCLC.

Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma

Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma.

FOX-A1 Contributes to Acquisition of Chemoresistance in Human Lung Adenocarcinoma Via Transactivation of SOX5.

PHD-finger Domain Protein 5A Functions As a Novel Oncoprotein in Lung Adenocarcinoma

GATA3-induced Vwf Upregulation in the Lung Adenocarcinoma Vasculature

SLC39A5 Promotes Lung Adenocarcinoma Cell Proliferation by Activating PI3K/AKT Signaling

JAK2/STAT3 Signaling Pathway Activation Mediates Tumor Angiogenesis by Upregulation of VEGF and Bfgf in Non-Small-cell Lung Cancer

15-Lipoxygenase-2/15(s)-hydroxyeicosatetraenoic Acid Regulates Cell Proliferation and Metastasis Via the STAT3 Pathway in Lung Adenocarcinoma.

Sox2 Enhances Breast Tumor Angiogenesis By Promoting The Transition Of Cancer Cell To Cd31+And Lyve-1+Cells

Interleukin-9 Promotes Tumorigenesis Through Augmenting Angiogenesis in Non-Small Cell Lung Cancer.

Pro-Angiogenesis Role of LINC00662 From Esophageal Squamous Cell Carcinoma Cells-Derived Extracellular Vehicles

Expressions and clinical significance of VEGF and Survivin in lung adenocarcinoma

Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway

Krüppel-Like Factor 5 Promotes Lung Tumorigenesis Through Upregulation of Sox4

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma